HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Izumi Komoto Selected Research

Gastrinoma

11/2017A primary hepatic gastrinoma accompanied by hyperplasia of multi-nodular Brunner's glands.
3/2011Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients.
1/2006Changing treatment strategy for gastrinoma in patients with Zollinger-Ellison syndrome.
12/2005GPR40 gene expression in human pancreas and insulinoma.
7/2005Multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas in Japan.
2/2005New pancreas-preserving total duodenectomy technique.
10/2002Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Izumi Komoto Research Topics

Disease

20Neoplasms (Cancer)
11/2020 - 01/2002
9Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2022 - 11/2012
7Gastrinoma
11/2017 - 10/2002
6Neoplasm Metastasis (Metastasis)
03/2020 - 03/2011
5Carcinoma (Carcinomatosis)
12/2017 - 09/2002
5Insulinoma
01/2015 - 11/2002
3Lymphatic Metastasis
03/2020 - 01/2002
3Glucagonoma
10/2013 - 11/2002
3Carcinogenesis
03/2003 - 09/2002
2Nausea
01/2022 - 10/2018
2Disease Progression
07/2020 - 01/2019
2Multiple Endocrine Neoplasia Type 1
11/2017 - 02/2005
2Islet Cell Adenoma (Islet Cell Tumors)
12/2005 - 11/2002
2Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison)
02/2005 - 10/2002
2Esophageal Squamous Cell Carcinoma
08/2003 - 01/2002
1Vomiting
01/2022
1Pseudarthrosis (Pseudoarthrosis)
12/2021
1Infections
12/2021
1Glomus Tumor (Glomus Tumors)
11/2020
1Liver Neoplasms (Liver Cancer)
03/2020
1Stomatitis
01/2019
1Exanthema (Rash)
01/2019
1Primitive Neuroectodermal Tumors (PNET)
10/2018
1Cholangiocarcinoma
04/2018
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2017
1Flatulence
01/2017
1Diabetes Mellitus
01/2017
1Cicatrix (Scar)
11/2016
1Rectal Neoplasms (Rectal Cancer)
11/2016
1Alcoholic Fatty Liver
01/2015
1Hepatocellular Carcinoma (Hepatoma)
01/2015
1Non-alcoholic Fatty Liver Disease
01/2015
1Fatty Liver
01/2015
1Hyperplasia
03/2011
1Vipoma (WDHA)
04/2009
1Diarrhea
04/2009
1Glycogen Storage Disease Type VI (Glycogenosis Type VI)
04/2009
1Amyloidosis
02/2005
1Hemorrhage
02/2005
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
02/2005

Drug/Important Bio-Agent (IBA)

5Somatostatin Receptors (Somatostatin Receptor)IBA
11/2021 - 04/2004
5CalciumIBA
11/2017 - 10/2002
4Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2022 - 01/2017
3Streptozocin (Streptozotocin)FDA Link
01/2022 - 07/2015
3Messenger RNA (mRNA)IBA
12/2005 - 01/2002
3nitrosobenzylmethylamineIBA
03/2003 - 09/2002
2lanreotide (Somatuline)FDA Link
11/2021 - 01/2017
2EverolimusFDA Link
11/2021 - 01/2019
2Chromogranin AIBA
11/2020 - 01/2017
2Octreotide (Sandostatin)FDA LinkGeneric
11/2017 - 04/2009
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2015 - 01/2012
2phorbol 12-pyrenebutyrate 13-(3,3,3-trifloro-2-diazopropioate)IBA
03/2011 - 02/2005
2SecretinFDA Link
03/2011 - 10/2002
2SecretagoguesIBA
03/2011 - 01/2006
1somatostatin receptor 2IBA
02/2022
1AntiemeticsIBA
01/2022
1Hematoxylin (Haematoxylon)IBA
11/2020
1Eosine Yellowish-(YS) (Eosin)IBA
11/2020
1VimentinIBA
11/2020
1SynaptophysinIBA
11/2020
1STAT6 Transcription FactorIBA
11/2020
1Cytotoxins (Cytolysins)IBA
07/2020
1Pharmaceutical PreparationsIBA
01/2019
1Fluorouracil (Carac)FDA LinkGeneric
10/2018
1Irinotecan (Camptosar)FDA LinkGeneric
12/2017
1Proton Pump InhibitorsIBA
11/2017
1GastrinsIBA
11/2017
1Parathyroid Hormone (Parathormone)IBA
11/2017
1PlatinumIBA
08/2017
1Cisplatin (Platino)FDA LinkGeneric
11/2016
1Etoposide (VP 16)FDA LinkGeneric
11/2016
1EnzymesIBA
01/2015
1Glucagon-Like Peptide 1 (GLP 1)IBA
10/2013
1Nimodipine (Modus)FDA LinkGeneric
03/2011
1SolutionsIBA
03/2011
1Type I Vasoactive Intestinal Polypeptide ReceptorsIBA
04/2009
1Peptides (Polypeptides)IBA
04/2009
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
04/2009
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
04/2009
1Monoclonal AntibodiesIBA
01/2007
1CD13 Antigens (Alanine Aminopeptidase)IBA
01/2007
1Tissue ExtractsIBA
12/2005
1Fatty Acids (Saturated Fatty Acids)IBA
12/2005
1GTP-Binding Proteins (G-Protein)IBA
12/2005
1ParaffinIBA
07/2005
1DNA (Deoxyribonucleic Acid)IBA
07/2005
1LigandsIBA
08/2003
1CCR7 ReceptorsIBA
08/2003
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
03/2003

Therapy/Procedure

8Therapeutics
10/2018 - 01/2004
6Drug Therapy (Chemotherapy)
10/2018 - 07/2015
3Hepatectomy
03/2020 - 11/2016
2Radiotherapy
03/2020 - 11/2016
2Adjuvant Chemotherapy
12/2017 - 11/2016
2Pancreaticoduodenectomy
11/2017 - 03/2011
1Reoperation
12/2021
1Operative Surgical Procedures
05/2019
1Aftercare (After-Treatment)
11/2016
1Pneumonectomy (Lung Volume Reduction)
11/2016
1Pancreatectomy
03/2011